The award ceremony for the winners of a total of 149 applications took place in front of 300 guests from business, politics and science at the Ballhaus Neue Welt in Zwickau. The IQ Innovation Award for Central Germany honours innovative, marketable products, processes and services in five clusters. The focus is on the innovative character of the products together with their marketability.
In the Life Sciences cluster, the prizes are awarded for innovations in biotechnology such as molecular and cell biological findings for the development and production of new therapeutics and diagnostics. This year there were 37 competitors in the Life Science cluster, against which oncgnostics GmbH prevailed with its innovation.
In the field of information technology, the prize was awarded to the bm|t portfolio company crowdarchitects GmbH from Erfurt.
As cluster winners, the companies receive extensive PR, marketing and consulting services. The IQ Innovation Award Central Germany is offered by the European Metropolitan Region of Central Germany and its city partners.